MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Post-movement beta rebound inhibits future movement

    E. Rhodes, A. Kharko, W. Gaetz, S. Hall (Plymouth, United Kingdom)

    Objective: To evaluate the potential inhibitory effect of post-movement beta rebound (PMBR) on future movement production. Background: Changes in the cortical power of beta oscillations within the…
  • 2017 International Congress

    Clinical Utility of Optimized Parameters for a Quantitative Analysis of 123I-ioflupane SPECT (DaTscan) Images

    G. Zubal, S. Tinaz, C. Chow, H. Blumenfeld, E. Louis (New Haven, CT, USA)

    Objective: Validate an automated analysis of DaTscan SPECT images on a representative cohort of patients for discriminating between Parkinson's Disease (PD) versus non-PD. Background: Quantitation…
  • 2017 International Congress

    Beta oscillatory changes during practice and retention of motor skills in healthy subjects and patients with PD

    A. Nelson (NY, USA)

    Objective: The objective is to define the relationship between increase in beta oscillatory changes with practice and retention of motor skills in normal healthy subject…
  • 2017 International Congress

    Altered attentional brain network in Parkinson’s disease with mild cognitive impairment

    J.H. Yang, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

    Objective: To investigate alterations in the attention network in Parkinson’s disease patients with mild cognitive impairment (PD-MCI). Background: MCI is a risk factor for dementia…
  • 2017 International Congress

    Neural Correlates Underlying Reward Processing and Decision-Making in Impulse Control Disorder in Parkinson´s Disease

    I. Navalpotro-Gomez, P. Paz-Alonso, P. Boddy, M. Delgado-Alvarado, H. Jimenez-Urbieta, A. Quiroga-Varela, B. Gago, M. Carreiras, M.C. Rodriguez-Oroz (San Sebastian, Spain)

    Objective: To investigate the functional neural basis of decision-making in PD-ICD subjects using a modified version of the Iowa Gambling Task (IGT) paradigm. Background: Impulse…
  • 2017 International Congress

    Does smoking impact dopamine neuronal loss in de novo Parkinson’s disease?

    Y. Lee, H.s. Yoo, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: To investigate whether smoking impacts striatal dopamine neuronal degeneration in Parkinson’s disease (PD), we compared striatal subregional dopamine transporter (DAT) binding between current-smokers and…
  • 2017 International Congress

    Morphometric changes in Parkinson’s disease manifesting freezing of gait

    S. Pietracupa, A. Suppa, N. Upadhyay, A. Zampogna, F. Di Biasio, G. Grillea, N. Modugno, G. Fabbrini, A. Berardelli, P. Pantano (Pozzilli, Italy)

    Objective: To study structural Gray Matter (GM) and White Matter (WM) changes in Parkinson’s Disease (PD) patients with Freezing of Gait (FOG). Background: FOG is…
  • 2017 International Congress

    Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients

    K. Kawabata, H. Watanabe, K. Hara, E. Bagarinao, N. Yoneyama, A. Ogura, K. Imai, M. Masuda, T. Yokoi, R. Ohdake, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: This study was designed to clarify the relationship between early cognitive decline and functional connectivity changes in non-demented Parkinson's disease (PD) patients. Background: Cognitive…
  • 2017 International Congress

    A follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease and atypical parkinsonian syndrome

    J. Horie, H. Fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Matsubara, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)

    Objective: To evaluate whether the hyperechogenic size of the substantia nigra changes with time in Parkinson's disease (PD) and atypical parkinsonian syndromes (APSs), such as…
  • 2017 International Congress

    Metabolic changes following transcranial magnetic resonance-guided focused ultrasound subthalamotomy

    R. Rodriguez-Rojas, R. Martinez-Fernandez, J. Pineda-Pardo, C. Sanchez-Catasus, M. del Alamo, J. Obeso (Mostoles, Spain)

    Objective: As part of a pioneer trial to investigate the use of transcranial magnetic resonance-guided focused ultrasound subthalamotomy (MRgFUS-STN) in Parkinson's disease (PD), this study addresses…
  • « Previous Page
  • 1
  • …
  • 1515
  • 1516
  • 1517
  • 1518
  • 1519
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley